Clinical outcomes of patients with newly diagnosed primary central nervous system lymphoma are comparable on treatment with high-dose methotrexate plus temozolomide and with high-dose methotrexate plus cytarabine: a single-institution experience. [electronic resource]
Producer: 20150720Description: 2497-501 p. digitalISSN:- 1029-2403
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Central Nervous System Neoplasms -- drug therapy
- Cytarabine -- administration & dosage
- Dacarbazine -- administration & dosage
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Female
- Humans
- Lymphoma -- drug therapy
- Male
- Methotrexate -- administration & dosage
- Middle Aged
- Neutropenia -- chemically induced
- Remission Induction
- Temozolomide
- Thrombocytopenia -- chemically induced
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.